Your browser doesn't support javascript.
loading
Selegiline: a molecule with innovative potential.
Tábi, Tamás; Vécsei, László; Youdim, Moussa B; Riederer, Peter; Szöko, Éva.
Afiliação
  • Tábi T; Department of Pharmacodynamics, Semmelweis University, Nagyvárad tér 4, 1089, Budapest, Hungary. tabi.tamas@pharma.semmelweis-univ.hu.
  • Vécsei L; Department of Neurology, Interdisciplinary Excellence Centre, MTA-SZTE Neuroscience Research Group, University of Szeged, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, Semmelweis u. 6, 6725, Szeged, Hungary.
  • Youdim MB; Technion-Rappaport Family Faculty of Medicine, Efron St, PO Box 9697, 31096, Haifa, Israel.
  • Riederer P; Clinic and Polyclinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany.
  • Szöko É; Department of Psychiatry, University of South Denmark, Odense, Denmark.
J Neural Transm (Vienna) ; 127(5): 831-842, 2020 05.
Article em En | MEDLINE | ID: mdl-31562557
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Selegilina / Fármacos Neuroprotetores / Inibidores da Monoaminoxidase Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Selegilina / Fármacos Neuroprotetores / Inibidores da Monoaminoxidase Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article